This gradient of RKIP loss was significantly associated with aggressive tumor features such as distant metastasis, vascular invasion, tumor budding, and infiltrative growth patterns, particularly when loss occurred in the tumor center. This evidence concerns the gene PEBP1 and neoplasm.